AU2003236700A1 - Mchr1 variant associated with human obesity - Google Patents
Mchr1 variant associated with human obesityInfo
- Publication number
- AU2003236700A1 AU2003236700A1 AU2003236700A AU2003236700A AU2003236700A1 AU 2003236700 A1 AU2003236700 A1 AU 2003236700A1 AU 2003236700 A AU2003236700 A AU 2003236700A AU 2003236700 A AU2003236700 A AU 2003236700A AU 2003236700 A1 AU2003236700 A1 AU 2003236700A1
- Authority
- AU
- Australia
- Prior art keywords
- mchr1
- human obesity
- variant associated
- variant
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101150106280 Mchr1 gene Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02012569 | 2002-06-05 | ||
EP02012569.6 | 2002-06-05 | ||
PCT/EP2003/005917 WO2003104489A2 (en) | 2002-06-05 | 2003-06-05 | Mchr1 variant associated with human obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003236700A1 true AU2003236700A1 (en) | 2003-12-22 |
Family
ID=29724376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003236700A Abandoned AU2003236700A1 (en) | 2002-06-05 | 2003-06-05 | Mchr1 variant associated with human obesity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003236700A1 (en) |
WO (1) | WO2003104489A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2305837A1 (en) * | 2005-05-11 | 2011-04-06 | Aarhus Universitet | Method for diagnosis and treatment of a mental disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000075166A1 (en) * | 1999-06-08 | 2000-12-14 | The Regents Of The University Of California | Melanin concentrating hormone receptor |
EP1288310A1 (en) * | 2001-08-31 | 2003-03-05 | Aventis Pharma Deutschland GmbH | Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight |
-
2003
- 2003-06-05 AU AU2003236700A patent/AU2003236700A1/en not_active Abandoned
- 2003-06-05 WO PCT/EP2003/005917 patent/WO2003104489A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003104489A2 (en) | 2003-12-18 |
WO2003104489A3 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003256338A1 (en) | Flexible splint | |
EP1578782A3 (en) | Combination therapy with co-stimulatory factors | |
GB0218526D0 (en) | Combination therapy | |
AU2003294318A1 (en) | Therapeutic bioconjugates | |
AU2003289694A1 (en) | Human body supporting device | |
AU2003247005A1 (en) | Therapy combination | |
AU2003249722A1 (en) | Therapeutic amides | |
AU2003245794A1 (en) | Glycosaminoglycan-dnase combination therapy | |
GB0219660D0 (en) | Therapeutic use | |
AU2003226899A1 (en) | Human diabetes-mediating proteins | |
AU2003261439A1 (en) | Massage device | |
AU2003282437A1 (en) | Crutch | |
AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
AU2003236700A1 (en) | Mchr1 variant associated with human obesity | |
AU2003212503A1 (en) | Food warmer | |
AU2003253499A1 (en) | Massage device | |
AU2003272870A1 (en) | Elastic massager | |
AU2003294687A1 (en) | Stethoscope with timer | |
AU2003231937A1 (en) | Therapeutic methods | |
AU2003208388A1 (en) | Flexible sheeting | |
AU2003287840A1 (en) | Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses | |
AU2002953547A0 (en) | Therapeutic combination | |
GB0213383D0 (en) | Therapeutic conditions | |
AU2003229752A1 (en) | Human rhomboid-related protein | |
AU2002953515A0 (en) | Therapeutic compounds - II |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |